University of Texas Rio Grande Valley
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Texas Rio Grande Valley sits in the upper quartile of US sponsors by registered trial count (#1,806 of 15,742 sponsors by registered trial count).
University of Texas Rio Grande Valley: 7 sponsored US clinical trials, 3 recruiting.
University of Texas Rio Grande Valley sponsors 7 registered US clinical trials on ClinicalTrials.gov, 3 of them currently recruiting, and 1 completed. 0 of these trials are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Spinal Cord Injuries, with 2 trials.
Upper-quartile sponsor footprint
University of Texas Rio Grande Valley sits in the upper quartile of the sponsor corpus (#1,806 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Open and recent trials
7 total, page 1 of 1
MH-POWER for College Students on the Spectrum
NCT07682753
Treatment Effects on Gait in Hammertoe Patients
NCT07166016
Reducing Foot Pain and Peak Plantar Pressure in Patients With Foot Pain
NCT06516900
South Texas Early Prevention Studies SNAP-Ed (STEPS SNAP-Ed)
NCT05851144
Targeted HD-tDCS to Improve Upper Limb Rehabilitation in SCI
NCT05589415
Temporary Inactivation of Strong Muscle Sensation to Improve Rehabilitation Interventions in SCI
NCT05589402
South Texas Early Prevention Studies PreK
NCT05501392
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
Therapeutic Areas
What is open in the University of Texas Rio Grande Valley pipeline
3 recruiting of 7 indexed (43% open); 1 completed (14%).
Phase mix: 0 late (III/IV) vs 1 early (I/II) (early-phase heavy).
Top condition: Spinal Cord Injuries (2 trials), 6 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Texas Rio Grande Valley: open-pipeline peers nationwide
Peers matched on 7 registered trials and 43% open enrollment, not the therapeutic-area sidebar.
University of Texas Rio Grande Valley sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 7 trials (± recruiting share)
- 3M · 7 trials · 0% recruiting
- 4Life Research · 7 trials · 0% recruiting
- 89bio · 7 trials · 29% recruiting
- Abbott Diagnostics Division · 7 trials · 0% recruiting
Sponsors near 43% open enrollment (± trial volume)
- Alphatec Spine · 43% recruiting · 7 trials
- Clarity Pharmaceuticals · 43% recruiting · 7 trials
- Colorado Center for Reproductive Medicine · 43% recruiting · 7 trials
- David Moss · 43% recruiting · 7 trials
Related
What to do with this University of Texas Rio Grande Valley page
7 registered trials is a research-attention snapshot, not an endorsement of University of Texas Rio Grande Valley or any single study.
- 3 of University of Texas Rio Grande Valley's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Spinal Cord Injuries is the condition University of Texas Rio Grande Valley studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Spinal Cord Injuries trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
University of Texas Rio Grande Valley pipeline card: 7 registered trials from official public datasets.Report a data error.